Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review
February 2019
50
About the Report
About the Report
Aurobindo Pharma Ltd (AUROPHARMA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Aurobindo Pharma Ltd (Aurobindo) is a vertically integrated pharmaceutical company that manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs). Its product portfolio is spread across major therapeutic and product categories including antibiotics, anti-retroviral, systemic gastroenterological, central nervous system (CNS), cardiovascular, anti-allergies, anti-diabetics, other therapeutic areas. The company also produces novel proprietary biocatalysts, dietary supplements and fermentation based semi synthetic products. Aurobindo operates manufacturing facilities in India, the US, Brazil and Portugal; and R&D facilities in India and the US. The company exports products to several countries worldwide. Aurobindo is headquartered in Hyderabad, Telangana, India.
Aurobindo Pharma Ltd Key Recent Developments
Jan 11,2019: Aurobindo Pharma to launch 147 drugs in different therapeutic segments in next 3 years
Dec 21,2018: Aurobindo Pharma to launch potassium chloride pills in US
Dec 18,2018: Suntuity delivers one of New Jersey's largest rooftop solar PV systems at Aurobindo Pharmaceuticals
Dec 02,2018: Aurobindo Pharma Expects First Biosimilar Approval In U.S. In 12-18 Months
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Aurobindo Pharma Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Mylan NV
Lupin Ltd
Hikal Ltd
Emcure Pharmaceuticals Ltd
Dr. Reddy's Laboratories Ltd
Divi's Laboratories Ltd
Cipla Ltd
Cadila Healthcare Ltd
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Aurobindo Pharma Ltd-Key Facts
Aurobindo Pharma Ltd-Key Employees
Aurobindo Pharma Ltd-Key Employee Biographies
Aurobindo Pharma Ltd-Major Products and Services
Aurobindo Pharma Ltd-History
Aurobindo Pharma Ltd-Company Statement
Aurobindo Pharma Ltd-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2-Company Analysis
Company Overview
Aurobindo Pharma Ltd-Business Description
Business Segment: API Segment
Overview
Performance
Business Segment: ARV Formulations
Overview
Performance
Business Segment: EU Formulations
Overview
Performance
Business Segment: Growth Markets Formulations
Overview
Performance
Business Segment: US Formulations
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: India
Performance
Geographical Segment: Rest of the world
Performance
Geographical Segment: USA
Performance
R&D Overview
Aurobindo Pharma Ltd-SWOT Analysis
SWOT Analysis-Overview
Aurobindo Pharma Ltd-Strengths
Aurobindo Pharma Ltd-Weaknesses
Aurobindo Pharma Ltd-Opportunities
Aurobindo Pharma Ltd-Threats
Aurobindo Pharma Ltd-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Aurobindo Pharma Ltd, Recent Deals Summary
Section 5-Company's Recent Developments
Oct 15, 2018: EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU Share
Jul 17, 2018: Aurobindo to buy Apotex's businesses in five European countries
May 28, 2018: Aurobindo Pharma Q4 FY17-18 and FY17-18 Financial Results
Mar 05, 2018: Aurobindo Pharma Issued Clarification on US FDA Observations
Mar 05, 2018: Aurobindo Announces Inspection of Unit 4 by US FDA
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Aurobindo Pharma Ltd, Performance Chart (2014-2018)
Aurobindo Pharma Ltd, Ratio Charts
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Aurobindo Pharma Ltd, Key Facts
Aurobindo Pharma Ltd, Key Employees
Aurobindo Pharma Ltd, Key Employee Biographies
Aurobindo Pharma Ltd, Major Products and Services
Aurobindo Pharma Ltd, History
Aurobindo Pharma Ltd, Other Locations
Aurobindo Pharma Ltd, Subsidiaries
Aurobindo Pharma Ltd, Joint Venture
Aurobindo Pharma Ltd, Key Competitors
Aurobindo Pharma Ltd, Ratios based on current share price
Aurobindo Pharma Ltd, Annual Ratios
Aurobindo Pharma Ltd, Annual Ratios (Cont...1)
Aurobindo Pharma Ltd, Annual Ratios (Cont...2)
Aurobindo Pharma Ltd, Interim Ratios
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Aurobindo Pharma Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.